Minerva Neurosciences (NERV) Other Working Capital Changes (2015 - 2018)
Minerva Neurosciences' (NERV) quarterly Other Working Capital Changes came in at -$1086.0 in Q4 2018, up 100.0% YoY from -$543.01 in Q4 2017, and down 83.45% on a QoQ basis from -$592.0 in Q3 2018.
Analysis
Minerva Neurosciences (NERV) Other Working Capital Changes (2015 - 2018) Analysis & Trends
Minerva Neurosciences (NERV) has 2 years of Other Working Capital Changes data on file, last reported at $37.1 million in Q3 2017.
- Quarterly Other Working Capital Changes rose 100.0% year-over-year to -$1086.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$888.0 (up 100.0% YoY) and the FY2018 annual result came in at -$888.0, down 102.97% from the prior year.
- Other Working Capital Changes slipped to -$1086.0 in Q4 2018, from -$592.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $395.0 in Q1 2018 to a low of -$41.1 million in Q4 2017.
- A 3-year average of -$5.1 million and a median of -$1825.0 in 2015 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 100.0% in 2018, down 100.0% in 2018.
- Tracing NERV's Other Working Capital Changes over 3 years: stood at -$2565.0 in 2015, then plunged by 1604021.72% to -$41.1 million in 2017, then surged by 100.0% to -$1086.0 in 2018.
- The last three Other Working Capital Changes figures came in at -$1086.0 (Q4 2018), -$592.0 (Q3 2018), and $395.0 (Q2 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -1,086.00 |
| Dec 31, 2018 | -1,086.00 |
| Sep 30, 2018 | -592.00 |
| Sep 30, 2018 | -592.00 |
| Jun 30, 2018 | 395.00 |
| Jun 30, 2018 | 395.00 |
| Mar 31, 2018 | 395.00 |
| Mar 31, 2018 | 395.00 |
| Dec 31, 2017 | -41.15 Mn |
| Dec 31, 2017 | -41.15 Mn |
| Sep 30, 2017 | 37.08 Mn |
| Sep 30, 2017 | 37.08 Mn |
| Jun 30, 2017 | 3.57 Mn |
| Jun 30, 2017 | 3.57 Mn |
| Mar 31, 2017 | 530,298.00 |
| Mar 31, 2017 | 530,298.00 |
| Dec 31, 2016 | -985,836.00 |
| Dec 31, 2016 | -985,836.00 |
| Dec 31, 2015 | 1.21 Mn |
| Dec 31, 2015 | 1.21 Mn |